[PDF][PDF] at baseline and after 2 cycles of chemotherapy in predicting pathologic complete response and outcomes in patients with triple-negative breast cancer …

JNM Page - THE JOURNAL OF NUCLEAR MEDICINE, 2016 - Soc Nuclear Med
This Month in JNM Page 1 Interventional molecular imaging: Solomon and Cornelis provide an
introductory focus on interventional opportunities for molecular imaging, including guidance to …

[PDF][PDF] Breast scintigraphy in triple negative breast cancer. Evaluation of the pattern and prediction of the chemotherapeutic response

KH Koga, SM Moriguchi, CPKC Pessoa, HS Freddi… - inis.iaea.org
BETA DECAY RADIOISOTOPES, BETA-MINUS DECAY RADIOISOTOPES, BODY,
COUNTING TECHNIQUES, DEVELOPING COUNTRIES, DIAGNOSTIC TECHNIQUES …

204P Predictive factors for relapse in triple-negative breast cancer (TNBC) patients without pathologic complete response (PCR)

M Venturelli, A Toss, M Civallero… - Annals of …, 2021 - annalsofoncology.org
Background Triple-negative breast cancer (TNBC) patients who do not obtain pathologic
complete response (pCR) after neoadjuvant chemotherapy (NACT) present higher rate of …

Diagnostic accuracy of 18F-FDG PET/CT in determining recurrence in patients with triple-negative breast cancer–A retrospective study.

SK Velliangiri, J Jaleel, R Kumar, C Bal, M Tripathi… - 2022 - Soc Nuclear Med
2982 Introduction: Recurrent triple-negative breast cancer is a rarely discussed area in
oncology. 18 F-FDG PET/CT plays an important role in detecting the recurrence of tumors in …

Is There Any Radiological Clue to Predict Tumor Recurrence in Triple Negative Breast Cancers?

BK Seo, SE Song, HS Kim, KR Cho, OH Woo, BH Kim - 2011 - epos.myesr.org
EPOS™ - C-2140 Brought to you by Browse Posters » Search result » Poster ECR 2011 / C-2140
POSTER SECTIONS Coverpage Learning objectives Background Imaging findings OR …

18FDG-PET/CT for the early evaluation of response to neoadjuvant treatment in triple negative breast cancer: influence of the chemotherapy regimen

L Biard, S Giacchetti, L Teixeira, E Hindie… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Patients with triple negative breast cancer (TNBC) have poor outcome when pathological
complete response (pCR) is not reached after neoadjuvant chemotherapy (NAC). Early …

Response to therapy in breast cancer

N Avril, S Sassen, R Roylance - Journal of Nuclear Medicine, 2009 - Soc Nuclear Med
Increasing numbers of patients with newly diagnosed breast cancer receive primary
systemic therapy followed by surgery. Histopathology provides an accurate assessment of …

Prognostic value of metabolic complete response on 18F-FDG PET/CT in stage II or III breast cancer patients treated with neoadjuvant chemotherapy

S Chen, NK Ibrahim, S Wong, H Wang, F Wong - 2015 - Soc Nuclear Med
288 Objectives A normal tracer distribution on 18F-FDG PET/CT after intiation of systemic
therapy can be regarded as metabolic complete response (mCR)[1]. The aim of this study is …

Abstract P4-11-04: The Influence of Radiation on Survival in Patients with Triple Negative Stage II Breast Cancer

B Hinton, J De Los Santos, K Keene, R Meredith… - Cancer Research, 2010 - AACR
Background: Prospective trials of locally advanced breast cancer patients treated with
adjuvant radiation (RT) have demonstrated a survival advantage; however, use of …

18F-FDG PET/CT for the early evaluation of response to neoadjuvant treatment in triple-negative breast cancer: influence of the chemotherapy regimen

D Groheux, L Biard, S Giacchetti… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Patients with triple-negative breast cancer (TNBC) have poor outcome when pathologic
complete response (pCR) is not reached after neoadjuvant chemotherapy. Early prediction …